Glucose transporter 1 deficiency in the idiopathic generalized epilepsies
Todor Arsov, Saul A Mullen, Sue Rogers, A Marie Phillips, Kate M Lawrence, John A Damiano, Hadassa Goldberg-Stern, Zaid Afawi, Sara Kivity, Chantal Trager, Steven Petrou, Samuel F Berkovic, Ingrid E Scheffer
Annals of Neurology | WILEY-BLACKWELL | Published : 2012
Awarded by National Health and Medical Research Council
This work was funded by a National Health and Medical Research Council program grant (6289521 awarded to S.P., S.F.B., I.E.S.).S.P.: consultancy, Sunovion Pharma. S. F. B.: honoraria, UCB; patents, patent for PCDH19 testing planned; patent for SCN1A testing held by Bionomics Inc and licensed to various diagnostic companies (no financial return); paid educational presentations, UCB Pharma, Novartis Pharmaceuticals, Sanofi-Aventis, Janssen-Cilag; consultancy, Bionomics, Athena Diagnostics. I. E. S.: board membership, Annals of Neurology, Epileptic Disorders (no funding received for either); speaking fees, UCB, Janssen-Cilag, Athena Diagnostics; patent pending, WO61/010176 (therapeutic compound); paid educational presentations, UCB, Athena Diagnostics; travel expenses, Athena Diagnostics, UCB, GSK, Biocodex.